Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries

• Corrado Barbui,
• Davide Papola,
• Beatrice Todesco,
• Chiara Gastaldon,
• Giovanni Ostuzzi

Affiliations

Corrado Barbui

ORCiD

WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy

Davide Papola

WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA

Beatrice Todesco

ORCiD

WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy

Chiara Gastaldon

WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy

Giovanni Ostuzzi

ORCiD

WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy